Dr. Amanda Kirane, MD, FACS, FSSO

Dr. Kirane is an assistant professor in the Department of Surgery, Section of Surgical Oncology, at Stanford University School of Medicine. Her research focuses on immune response and novel therapies in melanoma, and she has been the principal investigator of multiple translational and clinical studies with focus on mechanisms of innate immune targeting in melanoma. She has received funding from prestigious organizations such as the National Institutes of Health and the American Society of Clinical Oncology. Dr. Kirane has published articles in prominent journals including the Journal of Dermatological Treatment, Journal of Surgical Oncology, Journal of Surgical Research, and Annals of Surgery.

She has presented updates on melanoma management at conferences organized by the American College of Surgeons, Society of Surgical Oncology, and Society for Immunotherapy in Cancer. Dr. Kirane is a fellow of the American College of Surgeons and the Society of Surgical Oncology. She is a member of several professional organizations, including the Society for Immunotherapy of Cancer, American Association of Cancer Research, Society for Melanoma Research, Connective Tissue Oncology Society, Association of Academic Surgeons, and Association of Women Surgeons. In addition to her medical work, Dr. Kirane volunteers her time and expertise for various causes, including the Melanoma Research Foundation and STEM programs for children. She is also a certified Pilates instructor, Physician Wellness and Wellbeing Coach, and meditation teacher.

---

Media List

• Dr. Kirane discusses skin cancer

• Article on Dr. Kirane in Healthline

• Receiving ASCO 2020 Career Development Award for Women Who Conquer Cancer

• Dr. Amanda Kirane, UC Davis K12 scholar and surgical oncologist, presented her research on neoadjuvant therapy for melanoma

• Announced Drs. Dan Delitto and Dr. Amanda Kirane have been named John and Marva Warnock Faculty Scholars

• ACT2023  Dr. Kirane shares deep insight about neoadjuvant immunotherapy for clinically detected stage III melanoma

• Dr. Kirane received an SCI grant to study "Biomarker Analysis of Neoadjuvant Intralesional Therapy in High-Risk Melanoma

Education

• PhD Candidate, University of California at Davis, Immunology (2020)

• Board Certification: American Board of Surgery, Surgical Oncology (2018)

• Board Certification: American Board of Surgery, General Surgery (2017)

• Fellowship: Memorial Sloan Kettering Cancer Center Complex Surgical Oncology (2016) NY

• Residency: University of Texas Southwestern Medical Center (2014) TX

• Medical Education: University of Texas Southwestern Medical School Registrar (2006) TX